Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,733,797
-$16,729,412 QoQ
Shares Held
201,785
-68.2% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Sep 30, 2025CallValue
$2,609,750
CallShares
65,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. XENE ranks #95 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in XENE
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,733,797 | 201,785 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,463,209 | 635,056 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,609,750 | 65,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $55,567,881 | 1,384,007 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,632,735 | 882,835 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,852,578 | 234,056 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,564,768 | 346,040 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,229,353 | 209,026 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,846,020 | 175,584 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,601,606 | 83,661 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,545,007 | 76,965 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,537,200 | 45,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $3,262,040 | 95,493 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $341,600 | 10,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $8,213,513 | 213,338 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,926,411 | 221,470 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,442,751 | 594,541 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,228,598 | 560,349 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,987,660 | 492,691 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,167,485 | 136,326 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,831,000 | 90,621 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,609,426 | 236,219 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $687,600 | 45,000 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $229,200 | 15,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $5,618,547 | 301,748 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,137,892 | 342,899 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,405,385 | 416,475 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,315,614 | 118,845 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,106,669 | 167,996 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,195,072 | 193,569 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||